Correction to: Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension

Podobne zapisy

• Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
  od: Hoy, Sheridan M.
  Wydane: (2018)
• Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open‐angle glaucoma and ocular hypertension
  od: Fingeret, Murray, i wsp.
  Wydane: (2019)
• Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy
  od: Addis, Victoria M, i wsp.
  Wydane: (2018)
• Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
  od: Weinreb, Robert N., i wsp.
  Wydane: (2018)
• Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
  od: Kawase, Kazuhide, i wsp.
  Wydane: (2016)